| |
|
|
|
|
| Slide Lecture Programs |
| 2006 Core Curriculum |
| Contemporary Management of Myocardial Ischemia |
May 17, 2006
|
| V: |
New Therapeutic Options for Chronic Stable Angina |
Slide 50 |
|
Download PowerPoint
|
Ranolazine: Late Na+ current inhibitor
- Late Na+ current inhibitors appear to exert anti-ischemic and antianginal effects without any clinically significant pathophysiologic effects, providing complementary actions to older antianginal classes.
- Therefore, this new class of antianginal medications has potential in a wide range of patients.
|
|
|
Resources
